Skip to main content

SF Reaches $54M Settlement With Opioid Defendants Allergan and Teva

The city has reached a $54 million settlement with two opioid manufacturers, Allergen and Teva, the City Attorney’s Office announced Tuesday.

Under the terms of the agreement, the companies will pay $34 million in cash payments that will go to “opioid abatement and overdose prevention” and will provide a $20 million supply of Narcan, an opioid antidote.

That brings the total San Francisco has accrued so far in such settlements to $120 million.

“Under this agreement, our City will receive significant resources to combat the opioid crisis and bring relief to our communities,” City Attorney David Chiu said in a statement. “We look forward to presenting closing arguments in our trial against the remaining defendant, Walgreens, to make sure they are also held accountable for the crisis they fueled.”

Stay on top of what’s happening in your city

SF’s most important stories, delivered straight to your inbox

By clicking Subscribe you confirm you have read and agree to our Terms of Use and acknowledge our Privacy Policy